These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2926180)

  • 1. Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo.
    Horsman MR; Christensen KL; Overgaard J
    Int J Hyperthermia; 1989; 5(2):123-36. PubMed ID: 2926180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermoradiotherapy with hydralazine: the effect of preirradiation of the tumor bed on blood flow and growth delay of Ehrlich carcinoma.
    Kozin SV; Kozina LV
    Radiat Res; 1999 Jan; 151(1):79-84. PubMed ID: 9973088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent effects of hydralazine on microcirculatory function and hyperthermic response of murine FSall tumors.
    Kalmus J; Okunieff P; Vaupel P
    Cancer Res; 1990 Jan; 50(1):15-9. PubMed ID: 2293549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of tumour blood flow by vasoactive drugs: a role in cancer therapy.
    Chaplin DJ; Acker BD; Horsman MR
    Biomed Biochim Acta; 1989; 48(2-3):S264-8. PubMed ID: 2730621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo.
    Jordan A; Scholz R; Wust P; Fähling H; Krause J; Wlodarczyk W; Sander B; Vogl T; Felix R
    Int J Hyperthermia; 1997; 13(6):587-605. PubMed ID: 9421741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of hydralazine on the blood flow of normal and tumor tissues in hyperthermia].
    Ohshima T; Tanaka Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Aug; 53(8):960-9. PubMed ID: 8371944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hydralazine on the blood flow in RIF-1 tumors and normal tissues of mice.
    Lin JC; Song CW
    Radiat Res; 1990 Nov; 124(2):171-7. PubMed ID: 2247597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nitro-L-arginine on blood flow, oxygenation and the activity of hypoxic cell cytotoxins in murine tumours.
    Horsman MR; Chaplin DJ; Hill SA; Arnold S; Collingridge D; Radacic M; Wood PJ; Overgaard J
    Br J Cancer Suppl; 1996 Jul; 27():S168-71. PubMed ID: 8763873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
    Murata R; Horsman MR
    Int J Hyperthermia; 2004 Jun; 20(4):393-404. PubMed ID: 15204520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hydralazine-induced enhancement of hyperthermia treatment in vivo].
    Oshima T; Akagi K; Hasegawa T; Tanaka Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Nov; 52(11):1582-8. PubMed ID: 1465339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined adriamycin and hyperthermia treatment of a murine mammary carcinoma in vivo.
    Overgaard J
    Cancer Res; 1976 Sep; 36(9 pt.1):3077-81. PubMed ID: 975075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of nicotinamide and hyperthermia to eliminate radioresistant chronically and acutely hypoxic tumor cells.
    Horsman MR; Chaplin DJ; Overgaard J
    Cancer Res; 1990 Dec; 50(23):7430-6. PubMed ID: 2147577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The new vascular disrupting agent combretastatin-A1-disodium-phosphate (OXi4503) enhances tumour response to mild hyperthermia and thermoradiosensitization.
    Hokland SL; Horsman MR
    Int J Hyperthermia; 2007 Nov; 23(7):599-606. PubMed ID: 18038290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of thermotolerance during fractionated hyperthermia in a solid tumor in vivo.
    Kamura T; Nielsen OS; Overgaard J; Andersen AH
    Cancer Res; 1982 May; 42(5):1744-8. PubMed ID: 7066896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo.
    Donnelly ET; Kelley M; Rockwell S
    Cancer Chemother Pharmacol; 2004 Jan; 53(1):43-50. PubMed ID: 14574460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole.
    Murata R; Tsujitani M; Horsman MR
    Radiother Oncol; 2008 Jun; 87(3):331-8. PubMed ID: 18375007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hyperthermia on blood flow and cis-diamminedichloroplatinum(II) pharmacokinetics in murine mammary adenocarcinomas.
    Ausmus PL; Wilke AV; Frazier DL
    Cancer Res; 1992 Sep; 52(18):4965-8. PubMed ID: 1516052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous inhibition of the receptor kinase activity of vascular endothelial, fibroblast, and platelet-derived growth factors suppresses tumor growth and enhances tumor radiation response.
    Griffin RJ; Williams BW; Wild R; Cherrington JM; Park H; Song CW
    Cancer Res; 2002 Mar; 62(6):1702-6. PubMed ID: 11912143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between heat-induced vascular damage and thermosensitivity in four mouse tumors.
    Nishimura Y; Shibamoto Y; Jo S; Akuta K; Hiraoka M; Takahashi M; Abe M
    Cancer Res; 1988 Dec; 48(24 Pt 1):7226-30. PubMed ID: 3191494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of vasodilating drugs on pH in tumors.
    Adachi E; Tannock IF
    Oncol Res; 1999; 11(4):179-85. PubMed ID: 10566616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.